← Evidence map

SynthesisRheumatology international2021

Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?

C A Pereda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33656582